Boothbay Fund Management »

Biosante Pharmaceuticals shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.8M 23k 78.94
2019-12-31 $432k 7.0k 61.71

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Amazon Put Option (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Palantir Technologies Cl A Put Option (PLTR)
Abivax Sa Sponsored Ads (ABVX)
Alphabet Cap Stk Cl C Put Option (GOOG)
Mineralys Therapeutics Put Option (MLYS)
Advanced Micro Devices (AMD)
Microsoft Corporation (MSFT)
Invesco Exch Traded Fd Tr Ii S&p Midcp Low Call Option (XMLV)
Spdr Gold Tr Gold Shs Put Option (GLD)
Apple (AAPL)

View all positions for Boothbay Fund Management

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Group
State Street Corporation
Citadel Advisors
Global Alpha Capital Management
Dimensional Fund Advisors
Soleus Capital Management
Tang Capital Management
Deep Track Capital
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Deutsche Bank Aktiengesellschaft
Nuveen
Ranger Investment Management

View all funds holding Biosante Pharmaceuticals